ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
AIDS
◽
10.1097/qad.0b013e3283428cbe
◽
2011
◽
Vol 25
(4)
◽
pp. 479-492
◽
Cited By ~ 21
Author(s):
Andrea L Ciaranello
◽
Shahin Lockman
◽
Kenneth A Freedberg
◽
Michael Hughes
◽
Jennifer Chu
◽
...
Keyword(s):
South Africa
◽
Single Dose
◽
Cost Effectiveness
◽
Antiretroviral Therapy
◽
Cost Effectiveness Analysis
◽
First Line
◽
Effectiveness Analysis
◽
Single Dose Nevirapine
Download Full-text
Related Documents
Cited By
References
Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
Patient Related Outcome Measures
◽
10.2147/prom.s63586
◽
2015
◽
pp. 53
Author(s):
Giorgio Colombo
◽
Franco Maggiolo
◽
Sergio Di Matteo
◽
Giacomo Bruno
◽
Noemi Astuti
◽
...
Keyword(s):
Cost Effectiveness
◽
Antiretroviral Therapy
◽
Highly Active Antiretroviral Therapy
◽
Cost Effectiveness Analysis
◽
First Line
◽
Highly Active
◽
Effectiveness Analysis
Download Full-text
Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada
PharmacoEconomics
◽
10.1007/s40273-021-01022-9
◽
2021
◽
Author(s):
Yong-Jin Kim
◽
Mark Oremus
◽
Helen H. Chen
◽
Thomas McFarlane
◽
Danielle Fearon
◽
...
Keyword(s):
Lung Cancer
◽
Cost Effectiveness
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Egfr Mutation
◽
Cost Effectiveness Analysis
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Effectiveness Analysis
Download Full-text
P-2 First-line atezolizumab plus bevacizumab versus sorafenib in hepatocellular carcinoma: A cost-effectiveness analysis
Annals of Oncology
◽
10.1016/j.annonc.2021.05.057
◽
2021
◽
Vol 32
◽
pp. S97
Author(s):
S. Chan
◽
C. Chiang
◽
S. Lee
◽
H. Choi
Keyword(s):
Hepatocellular Carcinoma
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
First Line
◽
Effectiveness Analysis
Download Full-text
Atezolizumab and bevacizumab combination compared with sorafenib as the first‐line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost‐effectiveness analysis in China and the United states
Liver International
◽
10.1111/liv.14795
◽
2021
◽
Vol 41
(5)
◽
pp. 1097-1104
Author(s):
Feng Wen
◽
Hanrui Zheng
◽
Pengfei Zhang
◽
Weiting Liao
◽
Kexun Zhou
◽
...
Keyword(s):
United States
◽
Hepatocellular Carcinoma
◽
Cost Effectiveness
◽
Systemic Treatment
◽
The United States
◽
Cost Effectiveness Analysis
◽
First Line
◽
Effectiveness Analysis
◽
Unresectable Hepatocellular Carcinoma
Download Full-text
Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia
Value in Health
◽
10.1016/j.jval.2015.09.1188
◽
2015
◽
Vol 18
(7)
◽
pp. A460
◽
Cited By ~ 2
Author(s):
J Vargas-Valencia
◽
J Garcia Perlaza
Keyword(s):
Colorectal Cancer
◽
Cost Effectiveness
◽
Metastatic Colorectal Cancer
◽
Cost Effectiveness Analysis
◽
Line Treatment
◽
Wild Type
◽
First Line
◽
Effectiveness Analysis
◽
First Line Treatment
Download Full-text
Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa
Retrovirology
◽
10.1186/1742-4690-12-s1-p81
◽
2015
◽
Vol 12
(S1)
◽
Author(s):
Wendy Sykes
◽
Charl Coleman
◽
Genevieve Beck
◽
Jabu Mhlanga
◽
Carol Hlela
◽
...
Keyword(s):
South Africa
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer
Journal of Medical Economics
◽
10.1080/13696998.2017.1285780
◽
2017
◽
Vol 20
(6)
◽
pp. 574-584
◽
Cited By ~ 3
Author(s):
Fernando Rivera
◽
Manuel Valladares
◽
Salvador Gea
◽
Noemí López-Martínez
Keyword(s):
Colorectal Cancer
◽
Cost Effectiveness
◽
Metastatic Colorectal Cancer
◽
Cost Effectiveness Analysis
◽
Line Treatment
◽
Wild Type
◽
First Line
◽
Effectiveness Analysis
◽
First Line Treatment
Download Full-text
Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine For First-Line Treatment Of Patients with Metastatic Pancreatic Cancer from the US Societal Perspective
Value in Health
◽
10.1016/j.jval.2016.03.1607
◽
2016
◽
Vol 19
(3)
◽
pp. A153
Author(s):
W Cheng
◽
JW Hay
Keyword(s):
Pancreatic Cancer
◽
Cost Effectiveness
◽
Societal Perspective
◽
Cost Effectiveness Analysis
◽
Metastatic Pancreatic Cancer
◽
Line Treatment
◽
First Line
◽
Effectiveness Analysis
◽
The Us
◽
First Line Treatment
Download Full-text
Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
PLoS ONE
◽
10.1371/journal.pone.0033672
◽
2012
◽
Vol 7
(4)
◽
pp. e33672
◽
Cited By ~ 19
Author(s):
Antonieta Medina Lara
◽
Jesse Kigozi
◽
Jovita Amurwon
◽
Lazarus Muchabaiwa
◽
Barbara Nyanzi Wakaholi
◽
...
Keyword(s):
Cost Effectiveness
◽
Antiretroviral Therapy
◽
Cost Effectiveness Analysis
◽
Laboratory Monitoring
◽
Routine Laboratory
◽
Effectiveness Analysis
Download Full-text
Commentary on: A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder
International Urogynecology Journal
◽
10.1007/s00192-018-3662-y
◽
2018
◽
Vol 29
(8)
◽
pp. 1221-1221
Author(s):
Abdelmageed Abdelrahman
Keyword(s):
Cost Effectiveness
◽
Overactive Bladder
◽
Cost Effectiveness Analysis
◽
Line Treatment
◽
First Line
◽
Effectiveness Analysis
◽
Onabotulinumtoxin A
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close